- Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
- Precigen Reports Full Year 2023 Financial Results and Business Updates
- Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
- Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
- Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
More ▼
Key statistics
On Thursday, Precigen Inc (PGEN:NSQ) closed at 1.32, 58.01% above the 52 week low of 0.8354 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.30 |
---|---|
High | 1.36 |
Low | 1.28 |
Bid | 1.30 |
Offer | 1.34 |
Previous close | 1.31 |
Average volume | 804.68k |
---|---|
Shares outstanding | 248.92m |
Free float | 219.74m |
P/E (TTM) | -- |
Market cap | 326.08m USD |
EPS (TTM) | -0.3933 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 21:00 BST.
More ▼